TABLE 3

Total Distribution Volumes Derived with 1TC Model for 18F-SynVesT-1 and 11C-UCB-J Under Baseline and Levetiracetam Blocking Conditions

18F-SynVesT-1 (n = 4)11C-UCB-J (n = 4)
RegionBaselineBlockingBaselineBlocking
Putamen18.7 (18%)5.1 (14%)20.5 (14%)7.2 (10%)
Insular cortex18.4 (21%)4.9 (13%)19.6 (15%)6.9 (11%)
Temporal cortex18.8 (20%)4.6 (8%)20.4 (15%)6.8 (7%)
Parietal cortex18.1 (21%)4.3 (6%)20.1 (15%)6.6 (7%)
Amygdala17.4 (13%)4.7 (12%)19.1 (13%)7.0 (13%)
Occipital cortex17.7 (24%)4.2 (6%)19.5 (20%)6.3 (4%)
Anterior cingulate cortex17.6 (21%)4.8 (16%)19.0 (20%)7.0 (15%)
Frontal cortex17.1 (18%)4.3 (8%)18.8 (12%)6.4 (8%)
Caudate nucleus15.9 (15%)4.3 (12%)17.6 (14%)6.3 (12%)
Posterior cingulate cortex15.9 (32%)4.0 (9%)16.9 (28%)5.9 (19%)
Thalamus13.3 (14%)4.0 (13%)14.5 (12%)5.7 (6%)
Cerebellum13.0 (17%)3.6 (12%)13.7 (13%)5.2 (5%)
Hippocampus13.2 (13%)3.8 (11%)14.1 (10%)5.5 (10%)
Globus pallidus11.9 (27%)4.2 (14%)12.5 (18%)5.6 (6%)
CS3.6 (13%)2.4 (6%)4.5 (10%)3.4 (4%)
  • Data in parentheses represent %COV (percentage coefficient of variation [intersubject variability]).